Form D · Biotechnology
Taiga Biotechnologies, Inc.
Aurora, CO · CIK 0001488845
Offering snapshot reported Aug 16, 2022 · SEC filing
- Reported sold
- $14M Offering amount: $40M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 31, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$5,445,000 → $13,957,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 16, 2022 | Amendment | $13,957,000 | $8,512,000vs Aug 13, 2021 | 20 | SEC filing |
| Aug 13, 2021 | Amendment | $5,445,000 | No comparison | Not reported | SEC filing |
| Aug 13, 2020 | Initial | $1,080,000 | No comparison | 12 | SEC filing |
| Jun 10, 2019 | Initial | $3,002,356 | No comparison | 10 | SEC filing |
| Mar 27, 2018 | Amendment | $8,736,334 | $2,651,347vs Mar 28, 2017 | 20 | SEC filing |
| Mar 28, 2017 | Initial | $6,084,987 | No comparison | 14 | SEC filing |
| Jun 3, 2015 | Amendment | $11,999,968 | $8,799,971vs May 30, 2014 | 21 | SEC filing |
| May 30, 2014 | Initial | $3,199,997 | No comparison | 2 | SEC filing |
| Apr 15, 2010 | Initial | $246,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-373185
Source: Form D, filed Aug 16, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephanie Douglas | Director |
| Stephen K. Erkenbrack | Director |
| Stephen K. Erken Brack | Director |
| James L. Kelly | Executive |
| Robert Mashal | Director |
| Yosef Rafaeli | Director, Executive |
| Yosef Refaeli | Director |
| Daniel Ritchie | Director |
| David J. Rivers | Executive |
| Brian C. Turner | Director |
| Earl L. Wright | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2115 N. Scranton St. #3060 #3060
Aurora, CO, 80045
Aurora, CO, 80045